Crescita Therapeutics Inc
CTX.CA
$0.41
Closing
0.00
1D
▲16.33%
YTD
CTX
BBG008HJRTB7
Market cap
$7.97M
52 week high
$0.50
52 week low
$0.26
Volume
547
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$7.97M
Analysts' Rating
-
Price Target (Mean)
0
Total Analysts
0
P/E
Operating Margin
-23.09%
Beta
1.71
Revenue Growth
-20.81%
52 week high
$0.50
52 week low
$0.26
Div. Yield
%
EPS Growth
0
Company Profile
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. It also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
